Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
International Journal of Hematology|September 20, 2020
Beneficial tyrosine kinase inhibitor therapy in a patient with relapsed BCR-ABL1-like acute lymphoblastic leukemia with CCDC88C-PDGFRB fusionShuki Oya, Satoshi Morishige, Hidetoshi Ozawa, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 2, 2024
[Successful induction therapy for acute myeloid leukemia under management with extracorporeal membrane oxygenation]Yusuke Takaki, Toshiyuki Yanai, Tatsuhiro Shibata, et al.
International Journal of Hematology|June 23, 2021
A case of lymphomatoid granulomatosis with central nervous system involvement successfully treated with IFNαYoshitaka Yamasaki, Satoshi Morishige, Satoru Komaki, et al.
Haematologica|May 4, 2019
Myeloid differentiation factor 88 signaling in donor T cells accelerates graft-versus-host diseaseSatomi Matsuoka, Daigo Hashimoto, Masanori Kadowaki, et al.
The Oncologist|April 15, 2017
A Host-Dependent Prognostic Model for Elderly Patients with Diffuse Large B-Cell LymphomaKatsuhiro Miura, Jun Konishi, Takaaki Miyake, et al.
Blood|September 14, 2013
Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethalityAsim Saha, Kazutoshi Aoyama, Patricia A Taylor, et al.
Blood|July 2, 2013
Inhibiting retinoic acid signaling ameliorates graft-versus-host disease by modifying T-cell differentiation and intestinal migrationKazutoshi Aoyama, Asim Saha, Jakub Tolar, et al.
The Journal of Experimental Medicine|May 2, 2012
Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantationRobert R Jenq, Carles Ubeda, Ying Taur, et al.
Blood|September 25, 2020
Repurposing a novel anti-cancer RXR agonist to attenuate murine acute GVHD and maintain graft-versus-leukemia responsesGovindarajan Thangavelu, Chao Wang, Michael Loschi, et al.
The Journal of Clinical Investigation|June 14, 2016
Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethalityAsim Saha, Roddy S O'Connor, Govindarajan Thangavelu, et al.
Pageof 3